Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
AGN
Allergan plc
AGN
|
+$603M |
| 3 |
Meta Platforms (Facebook)
META
|
+$459M |
| 4 |
Alibaba
BABA
|
+$361M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$2.49B |
| 2 |
Qualcomm
QCOM
|
+$424M |
| 3 |
Oracle
ORCL
|
+$369M |
| 4 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$351M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.16% |
| 2 | Financials | 5.29% |
| 3 | Healthcare | 5.26% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Communication Services | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
First Merchants
FRME
$2.68B
| $649K | ﹤0.01% |
17,255
-3,111
| -15% | -$116K |
|
4027
Towne Bank
TOWN
$3.46B
| $649K | ﹤0.01% |
23,346
-1,017
| -4% | -$27.6K |
|
4028
Barclays
BCS
$92.7B
| $647K | ﹤0.01% |
88,047
+1,957
| +2% | +$14.2K |
|
4029
Compass Minerals
CMP
$1.23B
| $646K | ﹤0.01% |
11,444
+3,221
| +39% | +$173K |
|
4030
PUT
Tencent Music
TME
$15.5B
| $646K | ﹤0.01% |
50,600
-35,500
| -41% | -$500K |
|
4031
Century Communities
CCS
$1.91B
| $645K | ﹤0.01% |
21,052
+396
| +2% | +$11K |
|
|
TXNM
4032
TXNM Energy Inc
TXNM
$6.41B
| $642K | ﹤0.01% |
12,333
-3,875
| -24% | -$196K |
|
|
MDC
4033
CALL
DELISTED
M.D.C. Holdings, Inc.
MDC
| $642K | ﹤0.01% |
16,092
+11,016
| +217% | +$387K |
|
|
WPX
4034
CALL
DELISTED
WPX Energy, Inc.
WPX
| $642K | ﹤0.01% |
60,600
+22,800
| +60% | +$241K |
|
4035
Invesco Large Cap Growth ETF
PWB
$2.29B
| $641K | ﹤0.01% |
13,253
-483
| -4% | -$23.6K |
|
4036
CALL
Burlington
BURL
$23.2B
| $639K | ﹤0.01% |
3,200
+900
| +39% | +$165K |
|
4037
Chefs' Warehouse
CHEF
$4.71B
| $639K | ﹤0.01% |
15,841
-2,048
| -11% | -$76.7K |
|
|
DPLO
4038
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $638K | ﹤0.01% |
130,151
-5,367
| -4% | -$30K |
|
|
SPYM
4039
State Street SPDR Portfolio S&P 500 ETF
SPYM
$161B
| $637K | ﹤0.01% |
18,281
-1,052
| -5% | -$36.6K |
|
|
TYPE
4040
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $637K | ﹤0.01% |
32,145
+1,512
| +5% | +$28.8K |
|
|
STML
4041
DELISTED
Stemline Therapeutics, Inc.
STML
| $636K | ﹤0.01% |
61,088
+47,193
| +340% | +$617K |
|
4042
AngioDynamics
ANGO
$611M
| $635K | ﹤0.01% |
34,472
-464
| -1% | -$9.07K |
|
4043
PUT
Coherent
COHR
$51.4B
| $635K | ﹤0.01% |
+18,032
| New | +$687K |
|
|
LKFT
4044
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
| $635K | ﹤0.01% |
4,164
+3,521
| +548% | +$577K |
|
4045
Ingevity
NGVT
$2.51B
| $635K | ﹤0.01% |
7,473
-7,508
| -50% | -$669K |
|
4046
MacroGenics
MGNX
$235M
| $634K | ﹤0.01% |
49,666
-54,029
| -52% | -$778K |
|
|
MAGN
4047
Magnera Corp
MAGN
$472M
| $632K | ﹤0.01% |
3,159
-18
| -0.6% | -$3.6K |
|
4048
Fiverr
FVRR
$321M
| $631K | ﹤0.01% |
+33,750
| New | +$772K |
|
4049
GoPro
GPRO
$130M
| $631K | ﹤0.01% |
121,655
-217,885
| -64% | -$1.02M |
|
4050
Tandem Diabetes Care
TNDM
$1.34B
| $631K | ﹤0.01% |
10,686
+18
| +0.2% | +$1.15K |
|
Similar funds
Citigroup's Q3 2019 Portfolio in Review
As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
- Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
- Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
- Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
- Citigroup opened 182 new positions and closed 268 in Q3 2019.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.